CCL2 was previously identified as one of the major chemokines detected in the CSF of patients with HIV-associated CM and was associated with the risk for the development of life-threatening immune reconstitution inflammatory syndrome (IRIS) (19). This evidence concerns the gene CCL2 and cutaneous mastocytosis.